Download - WHOCC
Download - WHOCC
Download - WHOCC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
QG02CB<br />
QG02CC<br />
Prolactine inhibitors<br />
Antiinflammatory products for vaginal administration<br />
This group comprises e.g. non-steroidal antiinflammatory drugs for vaginal<br />
administration.<br />
QG02CX<br />
Other gynecologicals<br />
QG03<br />
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM<br />
Other hormones, see QH - Systemic hormonal preparations, excl. sex hormones and<br />
insulins.<br />
QG03A<br />
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE<br />
Hormonal preparations, which are used as contraceptives, should be classified here.<br />
Similar hormonal preparations which are used for estrus synchronization are<br />
classified in QG03F - Progestogens and estrogens in combination.<br />
QG03AA<br />
QG03AB<br />
QG03AC<br />
Progestogens and estrogens, fixed combinations<br />
Progestogens and estrogens, sequential products<br />
Progestogens<br />
Progestogens used as hormonal contraceptives are classified in this group.<br />
Progestogens for other gynecological uses are classified in QG03D.<br />
QG03AD<br />
Emergency contraceptives<br />
QG03B<br />
ANDROGENS<br />
Anabolic steroids are classified in QA14A - Anabolic steroids. Male sex hormones<br />
should be classified in this group. Combined products are included in this group,<br />
except for combinations with female sex hormones, which should be classified in<br />
QG03E - Androgens and female sex hormones in combination.<br />
The group is subdivided according to chemical structure.<br />
QG03BA<br />
QG03BB<br />
3-oxoandrosten (4) derivatives<br />
5-androstanon (3) derivatives<br />
75
Change language